<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36142222</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>18</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral Activity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10309</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms231810309</ELocationID><Abstract><AbstractText>Dengue virus (DENV) is one of the most geographically distributed mosquito-borne flaviviruses, like Japanese encephalitis virus (JEV), and Zika virus (ZIKV). In this study, a library of the known and novel Glycyrrhizic acid (GL) derivatives bearing amino acid residues or their methyl/ethyl esters in the carbohydrate part were synthesized and studied as DENV inhibitors in vitro using the cytopathic effect (CPE), viral infectivity and virus yield assays with DENV1 and DENV-2 in Vero E6 and A549 cells. Among the GL conjugates tested, compound hits GL-D-ValOMe 3, GL-TyrOMe 6, GL-PheOEt 11, and GL-LysOMe 21 were discovered to have better antiviral activity than GL, with IC50 values ranging from &lt;0.1 to 5.98 &#x3bc;M on the in vitro infectivity of DENV1 and DENV2 in Vero E6 and A549 cells. Compound hits 3, 6, 11, and 21 had a concentration-dependent inhibition on the virus yield in Vero E6, in which GL-D-ValOMe 3 and GL-PheOEt 11 were the most active inhibitors of DENV2 yield. Meanwhile, the time-of-addition assay indicated that conjugates GL-D-ValOMe 3 and GL-PheOEt 11 exhibited a substantial decrease in the DENV2 attachment stage. Subsequently, chimeric single-round infectious particles (SRIPs) of DENV2 C-prM-E protein/JEV replicon and DENV2 prM-E/ZIKV replicon were utilized for the DENV envelope I protein-mediated attachment assay. GL conjugates 3 and 11 significantly reduced the attachment of chimeric DENV2 C-prM-E/JEV and DENV2 prM-E/ZIKV SRIPs onto Vero E6 cells in a concentration-dependent manner but did not impede the attachment of wild-type JEV CprME/JEV and ZIKV prM-E/ZIKV SRIPs, indicating the inhibition of Compounds 3 and 11 on DENV2 E-mediated attachment. Molecular docking data revealed that Compounds 3 and 11 have hydrophobic interactions within a hydrophobic pocket among the interfaces of Domains I, II, and the stem region of the DENV2 envelope (E) protein. These results displayed that Compounds 3 and 11 were the lead compounds targeting the DENV E protein. Altogether, our findings provide new insights into the structure&#x2212;activity relationship of GL derivatives conjugated with amino acid residues and can be the new fundamental basis for the search and development of novel flavivirus inhibitors based on natural compounds.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hour</LastName><ForeName>Mann-Jen</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>School of Pharmacy, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yeh</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of New Drug Development, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chen-Sheng</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Kuang Tien General Hospital, No. 117 Shatian Road, Shalu District, Taichung 43303, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baltina</LastName><ForeName>Lidia A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0002-6291-5260</Identifier><AffiliationInfo><Affiliation>Ufa Institute of Chemistry, Ufa Federal Research Centre of RAS, 71 Prospect Oktyabrya, 450054 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kan</LastName><ForeName>Ju-Ying</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, 91, Hsueh-Shin Road, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Yan-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, Asia University, 500 Lioufeng Road, Wufeng, Taichung 41354, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiu</LastName><ForeName>Yan-Tung</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Hsueh-Chou</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>School of Chinese Medicine, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baltina</LastName><ForeName>Lia A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Ufa Institute of Chemistry, Ufa Federal Research Centre of RAS, 71 Prospect Oktyabrya, 450054 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrova</LastName><ForeName>Svetlana F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Ufa Institute of Chemistry, Ufa Federal Research Centre of RAS, 71 Prospect Oktyabrya, 450054 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Cheng-Wen</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0003-0165-2652</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, 91, Hsueh-Shin Road, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, Asia University, 500 Lioufeng Road, Wufeng, Taichung 41354, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002241">Carbohydrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>6FO62043WK</RegistryNumber><NameOfSubstance UI="D019695">Glycyrrhizic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002241" MajorTopicYN="N">Carbohydrates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="Y">Dengue Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004664" MajorTopicYN="Y">Encephalitis Virus, Japanese</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018349" MajorTopicYN="Y">Encephalitis Viruses, Japanese</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005416" MajorTopicYN="Y">Flavivirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019695" MajorTopicYN="N">Glycyrrhizic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="Y">Zika Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="Y">Zika Virus Infection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dengue virus</Keyword><Keyword MajorTopicYN="N">Glycyrrhizic acid</Keyword><Keyword MajorTopicYN="N">amino acids</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword><Keyword MajorTopicYN="N">derivatives</Keyword><Keyword MajorTopicYN="N">methyl/ethyl ester</Keyword><Keyword MajorTopicYN="N">molecular model</Keyword><Keyword MajorTopicYN="N">synthesis</Keyword></KeywordList><CoiStatement>All authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36142222</ArticleId><ArticleId IdType="pmc">PMC9499324</ArticleId><ArticleId IdType="doi">10.3390/ijms231810309</ArticleId><ArticleId IdType="pii">ijms231810309</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Daep C.A., Mu&#xf1;oz-Jord&#xe1;n J.L., Eugenin E.A. Flaviviruses, an expanding threat in public health: Focus on dengue, West Nile, and Japanese encephalitis virus. J. Neurovirol. 2014;20:539&#x2013;560. doi: 10.1007/s13365-014-0285-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-014-0285-z</ArticleId><ArticleId IdType="pmc">PMC4331079</ArticleId><ArticleId IdType="pubmed">25287260</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver S.C., Charlier C., Vasilakis N., Lecuit M. Zika, Chikungunya, and other emerging vector-borne viral diseases. Annu. Rev. Med. 2018;69:395&#x2013;408. doi: 10.1146/annurev-med-050715-105122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-050715-105122</ArticleId><ArticleId IdType="pmc">PMC6343128</ArticleId><ArticleId IdType="pubmed">28846489</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao-Lormeau V.-M., Musso D. Emerging arboviruses in the Pacific. Lancet. 2014;384:1571&#x2013;1572. doi: 10.1016/S0140-6736(14)61977-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61977-2</ArticleId><ArticleId IdType="pubmed">25443481</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler D.J. Dengue, urbanization and globalization: The unholy trinity of the 21st century. Trop. Med. Health. 2011;39:3&#x2013;11. doi: 10.2149/tmh.2011-S05.</Citation><ArticleIdList><ArticleId IdType="doi">10.2149/tmh.2011-S05</ArticleId><ArticleId IdType="pmc">PMC3317603</ArticleId><ArticleId IdType="pubmed">22500131</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons C.P., Farrar J.J., Chau N., Wills B. Dengue. N. Engl. J. Med. 2012;366:1423&#x2013;1432. doi: 10.1056/NEJMra1110265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1110265</ArticleId><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A., Ooi E.-E., Vasudevan S.G., Gubler D.J. Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development. Curr. Infect. Dis. Rep. 2010;12:157&#x2013;164. doi: 10.1007/s11908-010-0102-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-010-0102-7</ArticleId><ArticleId IdType="pubmed">21308524</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO/PAHO Epidemiological Update Dengue and other Arboviruses.  [(accessed on 28 July 2022)].  Available online:  https://reliefweb.int/report/argentina/epidemiological-update-dengue-and-other-arboviruses-10-june-2020.</Citation></Reference><Reference><Citation>World Health Organization . Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. World Health Organization; Geneva, Switzerland: 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">23762963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., Drake J.M., Brownstein J.S., Hoen A.G., Sankoh O., et al. The global distribution and burden of dengue. Nature. 2013;496:507&#x2013;594. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.M., Mohammed A.T., Vu T.T., Khattab M., Dohein M.F., Mohamed A.A., Abdelhamed M.M., Shamandy B.E., Dawod M.T., Alesaei W.A., et al. Prevelance and burden of dengue infection in Europe: A systematic review and meta-analysis. Rev. Med. Virol. 2019;30:e2093. doi: 10.1002/rmv.2093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2093</ArticleId><ArticleId IdType="pubmed">31833169</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens A.J., Gahan M.E., Mahalingam S., Keller P.A. The medicinal chemistry of Dengue Fever. J. Med. Chem. 2009;52:7911&#x2013;7926. doi: 10.1021/jm900652e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm900652e</ArticleId><ArticleId IdType="pubmed">19739651</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M.S., Pierson T.C. Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control. Cell. 2015;162:488&#x2013;492. doi: 10.1016/j.cell.2015.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.005</ArticleId><ArticleId IdType="pmc">PMC4522276</ArticleId><ArticleId IdType="pubmed">26232221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zonetti L.F.C., Coutinho M.C., De Araujo A.S. Molecular aspects of Denge virus infection process: A review. Protein Pept. Lett. 2018;25:712&#x2013;719. doi: 10.2174/0929866525666180709115506.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929866525666180709115506</ArticleId><ArticleId IdType="pubmed">29984641</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrell S., Wu S.-C., Butler M. Review of dengue virus and development of a vaccine. Biotechnol. Adv. 2011;29:239&#x2013;247. doi: 10.1016/j.biotechadv.2010.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biotechadv.2010.11.008</ArticleId><ArticleId IdType="pubmed">21146601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.-S. Current challenges in the development of vaccines and drugs against emerging vector-borne diseases. Curr. Med. Chem. 2019;26:2974&#x2013;2986. doi: 10.2174/0929867325666181105121146.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867325666181105121146</ArticleId><ArticleId IdType="pubmed">30394204</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah A.A., Lee Y.K., Chin S.P., Lim S.K., Lee V.S., Othman R., Othman S., Rahman N.A., Yusof R., Heh C.H. Discovery of Dengure virus inhibitors. Curr. Med. Chem. 2020;27:4945&#x2013;5036. doi: 10.2174/0929867326666181204155336.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867326666181204155336</ArticleId><ArticleId IdType="pubmed">30514185</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong S., Dimopoulos G. Antiviral Compounds for Blocking Arboviral Transmission in Mosquitoes. Viruses. 2021;13:108&#x2013;122. doi: 10.3390/v13010108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010108</ArticleId><ArticleId IdType="pmc">PMC7830659</ArticleId><ArticleId IdType="pubmed">33466915</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble C.G., Chen Y.-L., Dong H., Gu F., Lim S.P., Schul W., Wang Q.-Y., Shi P.-Y. Strategies for development of dengue virus inhibitors. Antiviral Res. 2010;85:450&#x2013;462. doi: 10.1016/j.antiviral.2009.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.12.011</ArticleId><ArticleId IdType="pubmed">20060421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampath A., Padmanabhan R. Molecular targets for flavivirus drug discovery. Antivir. Res. 2009;81:6&#x2013;15. doi: 10.1016/j.antiviral.2008.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2008.08.004</ArticleId><ArticleId IdType="pmc">PMC2647018</ArticleId><ArticleId IdType="pubmed">18796313</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadav S.S., Kaptein S., Timiri A., De Burghgrave T., Badavath V.N., Ganesan R., Sinha B.N., Neyts J., Leyssen P., Jayaprakash V. Design, synthesis optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors. Bioorg. Med. Chem. Lett. 2015;25:1745&#x2013;1752. doi: 10.1016/j.bmcl.2015.02.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2015.02.059</ArticleId><ArticleId IdType="pubmed">25791449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lescar J., Luo D., Xu T., Sampath A., Lim S.P., Canard B., Vasudevan S.G. Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from Dengue virus as a target. Antivir. Res. 2008;80:94&#x2013;101. doi: 10.1016/j.antiviral.2008.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2008.07.001</ArticleId><ArticleId IdType="pubmed">18674567</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Zhang B., Shi P.-Y. Flavirus methyltransferase: A novel antiviral target. Antivir. Res. 2008;80:1&#x2013;10. doi: 10.1016/j.antiviral.2008.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2008.05.003</ArticleId><ArticleId IdType="pmc">PMC3214650</ArticleId><ArticleId IdType="pubmed">18571739</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlinson S.M., Malmstrom R.D., Russo A., Mueller N., Pang Y.-P., Watowich S.J. Structure-based discovery of dengue virus protease inhibitors. Antivir. Res. 2009;82:110&#x2013;114. doi: 10.1016/j.antiviral.2009.02.190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.02.190</ArticleId><ArticleId IdType="pmc">PMC2680748</ArticleId><ArticleId IdType="pubmed">19428601</ArticleId></ArticleIdList></Reference><Reference><Citation>De Clercq E., Li G. Approved Antiviral Drugs over the Past 50 Years. Clin. Microbiol. Rev. 2016;29:695&#x2013;747. doi: 10.1128/CMR.00102-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00102-15</ArticleId><ArticleId IdType="pmc">PMC4978613</ArticleId><ArticleId IdType="pubmed">27281742</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez J.P., Sasse F., Bronstrup M., Diez J., Meyerhans A. Antiviral drug discovery: Broad-spectrum drugs from nature. Nat. Prod. Rep. 2015;32:29&#x2013;48. doi: 10.1039/C4NP00085D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4NP00085D</ArticleId><ArticleId IdType="pubmed">25315648</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan S., Tahs M.M.E., Makeen H.A., Alhazmi H.A., Al Bratty M., Sultana S., Ahsan W., Najmi A., Khalid A. Bioactive Natural Antivirals: An Updated Review of the Available Plants isolated Molecules. Molecules. 2020;25:4878&#x2013;4913. doi: 10.3390/molecules25214878.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25214878</ArticleId><ArticleId IdType="pmc">PMC7659943</ArticleId><ArticleId IdType="pubmed">33105694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Yang R., Yuan B., Liu Y., Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm. Sin. B. 2015;5:310&#x2013;315. doi: 10.1016/j.apsb.2015.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2015.05.005</ArticleId><ArticleId IdType="pmc">PMC4629407</ArticleId><ArticleId IdType="pubmed">26579460</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolstikov G.A., Baltina L.A., Grankina V.P., Kondratenko R.M., Tolstikova T.G. Licorice: Biodiversity, Chemistry, and Application in Medicine. Academic Publishing House &#x201c;Geo&#x201d;; Novosibirsk, Russia: 2007. pp. 147&#x2013;186. (In Russian)</Citation></Reference><Reference><Citation>Musayeva S., Valiyeva M., Madatli F., Mehraliyeva S., Khalilov R., Vahedi P., Eftekhari A. Prospects for the development of drugs with antiviral activity based on licorice. Eurasian Chem. Comm. 2021;3:301&#x2013;309. doi: 10.22034/ECC.2021.275909.1142.</Citation><ArticleIdList><ArticleId IdType="doi">10.22034/ECC.2021.275909.1142</ArticleId></ArticleIdList></Reference><Reference><Citation>Pompei R., Laconi S., Ingianni A. Antiviral properties of Glycyrrhizic acid and its semisynthetic derivatives. Mini-Rev. Med. Chem. 2009;9:996&#x2013;1001. doi: 10.2174/138955709788681636.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138955709788681636</ArticleId><ArticleId IdType="pubmed">19601894</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z.-G., Zhao T.-T., Lu N., Yang Y.-A., Zhu H.-L. Research progress of Glycyrrhizic acid on antiviral activity. Mini-Rev. Med. Chem. 2019;19:826&#x2013;832. doi: 10.2174/1389557519666190119111125.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557519666190119111125</ArticleId><ArticleId IdType="pubmed">30659537</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Kondratenko R.M., Baltina L.A., Jr., Plyasunova O.A., Pokrovskyi A.G., Tolstikov G.A. Prospects for the creation of new antiviral drugs based on Glycyrrhizic acid and its derivatives. Pharm. Chem. J. 2009;43:539&#x2013;548. doi: 10.1007/s11094-010-0348-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11094-010-0348-2</ArticleId><ArticleId IdType="pmc">PMC7089237</ArticleId><ArticleId IdType="pubmed">32214533</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L., Kondratenko R. Glycyrrhizic Acid Derivatives as New Antiviral and Immune Modulating Agents (a review) Curr. Bioact. Compds. 2021;17:41&#x2013;58. doi: 10.2174/1573407216666200210122751.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573407216666200210122751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato H., Goto W., Yamamura J., Kurokava M., Kageyama S., Takahara T., Watanabe A., Shiraki K. Therapeutic basis of glycyrrhizin in chronic hepatitis B. Antivir. Res. 1996;30:171&#x2013;177. doi: 10.1016/0166-3542(96)00942-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(96)00942-4</ArticleId><ArticleId IdType="pubmed">8783808</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto Y., Matsuura T., Aoyagi H., Matsuda M., Hmwe S.S., Date T., Watanabe N., Watashi K., Suzuki R., Ichinose S., et al. Antiviral activity of Glycyrrhizin against hepatitis C virus in vitro. PLoS ONE. 2013;8:e68992. doi: 10.1371/journal.pone.0068992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068992</ArticleId><ArticleId IdType="pmc">PMC3715454</ArticleId><ArticleId IdType="pubmed">23874843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashfaq U.A., Masoud M.S., Nawaz Z., Riazuddin S. Glycyrrhizin as antiviral agent against Hepatitis C Virus. J. Transl. Med. 2011;9:112. doi: 10.1186/1479-5876-9-112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-9-112</ArticleId><ArticleId IdType="pmc">PMC3169469</ArticleId><ArticleId IdType="pubmed">21762538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito M., Sato A., Hirabayashi K., Tanabe F., Shigeta S., Baba M., De Clerq E., Nakashima H., Yamamoto N. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV) Antivir. Res. 1988;10:289&#x2013;298. doi: 10.1016/0166-3542(88)90047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(88)90047-2</ArticleId><ArticleId IdType="pubmed">3250333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikegami N., Kinoshita S., Kanesaki T., Uno K., Akatani K., Kisida T. Evalluation of long term treatment with glycyrrhizin and of combination therapy with glycyrrhizin and AZT or DDI on HIV-1 carries. Antivir. Res. 1996;30:A33. doi: 10.1016/0166-3542(96)80279-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(96)80279-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A. Chemical Modification of Glycyrrhizic Acid As A Route to New Bioactive Compounds for Medicine. Curr. Med. Chem. 2003;10:155&#x2013;171. doi: 10.2174/0929867033368538.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867033368538</ArticleId><ArticleId IdType="pubmed">12570715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoever G., Baltina L.A., Michaelis M., Kondratenko R., Baltina L.A., Jr., Tolstikov G.A. Antiviral activity of Glycyrrhizic acid derivatives against SARS-Coronavirus. J. Med. Chem. 2005;48:1256&#x2013;1259. doi: 10.1021/jm0493008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm0493008</ArticleId><ArticleId IdType="pubmed">15715493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.C., Cherng J.M., Hung M.S., Baltina L.A., Baltina L.A., Kondratenko R.M. Inhibitory effects of some derivatives of Glycyrrhizic acid against Epstein-Barr virus infection: Structure-activity relationships. Antivir. Res. 2008;79:6&#x2013;11. doi: 10.1016/j.antiviral.2008.01.160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2008.01.160</ArticleId><ArticleId IdType="pmc">PMC7114209</ArticleId><ArticleId IdType="pubmed">18423902</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Zarubaev V.V., Baltina L.A., Orshanskaya I.A., Fairushina A.I., Kiselev O.I., Yunusov M.S. Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors. Bioorg. Med. Chem. Lett. 2015;25:1742&#x2013;1746. doi: 10.1016/j.bmcl.2015.02.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2015.02.074</ArticleId><ArticleId IdType="pmc">PMC7127794</ArticleId><ArticleId IdType="pubmed">25801933</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairushina A.I., Baltina L.A., Jr., Baltina L.A., Konovalova N.I., Petrova P.A., Eropkin M.Y. Synthesis and antiviral activity of novel Glycyrrhizic acid conjugates with D-amino acid esters. Russ. J. Bioorg. Chem. 2017;43:456&#x2013;462. doi: 10.1134/S1068162017040045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S1068162017040045</ArticleId><ArticleId IdType="pmc">PMC7088872</ArticleId><ArticleId IdType="pubmed">32214781</ArticleId></ArticleIdList></Reference><Reference><Citation>Crance J.M., Scaramozzino N., Jouan A., Garin D. Interferon, Ribavirin, 6-Azauridine and Glycyrrhizin: Antiviral Compounds Active against Pathogenic Flaviviruses. Antivir. Res. 2003;58:73&#x2013;77. doi: 10.1016/S0166-3542(02)00185-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-3542(02)00185-7</ArticleId><ArticleId IdType="pubmed">12719009</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Tasi Y.-T., Huang S.-H., Lai H.-C., Baltina L.A., Petrova S.F., Yunusov M.S., Lin C.W. Glycyrrhizic acid derivatives as Dengue virus inhibitors. Bioorg. Med. Chem. Lett. 2019;29:126645. doi: 10.1016/j.bmcl.2019.126645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2019.126645</ArticleId><ArticleId IdType="pmc">PMC7172207</ArticleId><ArticleId IdType="pubmed">31519375</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Hour M.-J., Liu Y.-C., Chang Y.-S., Huang S.-H., Lai H.-C., Kondratenko R.M., Petrova S.F., Yunusov M.S., Lin C.-W. Antiviral activity of glycyrrhizic acid conjugates with amino acid esters against Zika virus. Virus Res. 2021;294:198290. doi: 10.1016/j.virusres.2020.198290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198290</ArticleId><ArticleId IdType="pubmed">33388394</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Sapozhnikova T.A., Gabdrakhmanova S.F., Makara N.S., Khisamutdinova R.Y., Baltina L.A., Jr., Petrova S.F., Saifullina D.R., Kondratenko R.M. Hypoglycemic activity of Glycyrrhizic acid and some of its derivatives in the alloxan diabetes model in rats. Pharm. Chem. J. 2021;55:340&#x2013;344. doi: 10.1007/s11094-021-02424-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11094-021-02424-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Baltina L.A., Jr., Kondratenko R.M., Petrova S.F. 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide in the synthesis of glycyrrhizic acid amino-acid conjugates. Chem. Nat. Compd. 2020;56:569&#x2013;571. doi: 10.1007/s10600-020-03095-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10600-020-03095-y</ArticleId><ArticleId IdType="pmc">PMC7272590</ArticleId><ArticleId IdType="pubmed">32836317</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Jr., Kondratenko R.M., Baltina L.A., Baschenko N.Z., Plyasunova O.A. Synthesis and biological activity of new Glycyrrhizic acid conjugates with amino acids and dipeptides. Russ. J. Bioorg. Chem. 2009;35:510&#x2013;517. doi: 10.1134/S1068162009040141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S1068162009040141</ArticleId><ArticleId IdType="pmc">PMC7088709</ArticleId><ArticleId IdType="pubmed">19928060</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Jr., Kondratenko R.M., Baltina L.A., Plyasunova O.A., Galin F.Z., Tolstikov G.A. Synthesis of Glycyrrhizic acid conjugates containing L-lysine. Chem. Nat. Compd. 2006;42:543&#x2013;548. doi: 10.1007/s10600-006-0210-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10600-006-0210-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratenko R.M., Baltina L.A., Vasil&#x2019;eva E.V., Nasyrov K.M., Kireeva R.M., Baschenko N.Z., Fridman S.M., Baltina L.A., Jr., Tolstikov G.A. Synthesis and immunomodulating activity of new amino acid derivatives of Glycyrrhizic acid and its methyl ester. Russ. J. Bioorg. Chem. 2004;30:148&#x2013;153. doi: 10.1023/B:RUBI.0000023100.52170.6b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:RUBI.0000023100.52170.6b</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit J., Moesker B., Rodenhuis-Zybert I., Wilschut J. Flavivirus cell entry and membrane fusion. Viruses. 2011;3:160&#x2013;171. doi: 10.3390/v3020160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3020160</ArticleId><ArticleId IdType="pmc">PMC3206597</ArticleId><ArticleId IdType="pubmed">22049308</ArticleId></ArticleIdList></Reference><Reference><Citation>Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in dengue virus ebvelope glycoprotein. Proc. Natl. Acad. Sci. USA. 2003;100:6986&#x2013;6991. doi: 10.1073/pnas.0832193100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0832193100</ArticleId><ArticleId IdType="pmc">PMC165817</ArticleId><ArticleId IdType="pubmed">12759475</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldescu V., Behnam M.A.M., Vasilakis N., Klein C.D. Broad-spectrum agents for flaviviral infrctions: Dengue, Zika and beyond. Nat. Rev. Drug Discov. 2017;16:565&#x2013;586. doi: 10.1038/nrd.2017.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2017.33</ArticleId><ArticleId IdType="pmc">PMC5925760</ArticleId><ArticleId IdType="pubmed">28473729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Khaliq M., Suk J.-E., Patkar C., Li L., Kuhn R.J., Post C.B. Antiviral compounds discovered by virtual screening of small-molecule libraries against Dengue virus E Protein. Ach. Chem. Biol. 2008;3:765&#x2013;775. doi: 10.1021/cb800176t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb800176t</ArticleId><ArticleId IdType="pmc">PMC2782732</ArticleId><ArticleId IdType="pubmed">19053243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampmann T., Yennamalli R., Campbell P., Stoermer M.J., Fairlie D.P., Kobe B., Young P.R. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antivir. Res. 2009;84:234&#x2013;241. doi: 10.1016/j.antiviral.2009.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.09.007</ArticleId><ArticleId IdType="pubmed">19781577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuardia C., Stephens D.H., Dang H.T., Quijada M., Larionov O.V., Lleonart R. Antiviral activity of novel quinolone derivatives against Dengue virus serotype 2. Molecules. 2018;23:672. doi: 10.3390/molecules23030672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23030672</ArticleId><ArticleId IdType="pmc">PMC5997395</ArticleId><ArticleId IdType="pubmed">29547522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratenko R.M., Baltina L.A., Mustafina S.R., Makarova N.V., Nasyrov K.M., Tolstikov G.A. Crystalline Glycyrrhizic acid synthesized from commercial Glycyrrham. Immunomodulant properties of high-purity Glycyrrhizic acid. Pharm. Chem. J. 2001;35:101&#x2013;104. doi: 10.1023/A:1010481123359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010481123359</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Lai H.C., Liu Y.C., Huang S.H., Hour M.J., Baltina L.A., Nugumanov T.R., Borisevich S.S., Khalilov L.M., Petrova S.F., et al. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro. Bioorg. Med. Chem. 2021;41:116204. doi: 10.1016/j.bmc.2021.116204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2021.116204</ArticleId><ArticleId IdType="pubmed">34022526</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsypysheva I.P., Lai H.C., Kiu Y.T., Koval&#x2019;skaya A.V., Tsypyshev D.O., Huang S.H., Lin C.W. Synthesis and antiviral evaluation of cytisine derivatives against dengue virus types 1 and 2. Bioorg. Med. Chem. Lett. 2021;54:128437. doi: 10.1016/j.bmcl.2021.128437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2021.128437</ArticleId><ArticleId IdType="pubmed">34737087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan M.A. Determination of 50% endpoint titer using a simple formula. World J. Virol. 2016;5:85&#x2013;86. doi: 10.5501/wjv.v5.i2.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v5.i2.85</ArticleId><ArticleId IdType="pmc">PMC4861875</ArticleId><ArticleId IdType="pubmed">27175354</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.Y., Hour M.J., Wang C.Y., Huang S.H., Mu W.X., Chang Y.C., Lin C.W. Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus. Viruses. 2017;9:76. doi: 10.3390/v9040076.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9040076</ArticleId><ArticleId IdType="pmc">PMC5408682</ArticleId><ArticleId IdType="pubmed">28394283</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.Y., Lin C.S., Lai H.C., Yu Y.W., Liao C.Y., Su W.C., Ko B.H., Chang Y.S., Huang S.H., Lin C.W. The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles. Viruses. 2019;11:1005. doi: 10.3390/v11111005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11111005</ArticleId><ArticleId IdType="pmc">PMC6893733</ArticleId><ArticleId IdType="pubmed">31683628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J.M., Newton N.D., Modhiran N., Scott C., Venugopal H., Vet L.J., Young P.R., Hall R.A., Hobson-Peters J., Coulibaly F., et al. A unified route for flavivirus structures uncovers essential pocket factors conserved across pathogenic viruses. Nat. Commun. 2021;12:3266. doi: 10.1038/s41467-021-22773-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22773-1</ArticleId><ArticleId IdType="pmc">PMC8169900</ArticleId><ArticleId IdType="pubmed">34075032</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>